European AIDS Treatment Group

EU Institutions and Executive Agencies
DG Sanco – Health and Consumer Protection; DG Enterprise and Industry; DG Research; DG Trade; European Parliament; European Medicines Agency (EMA); European Monitoring Centre for Drugs and Drug Addiction (EMCDDA); European Centre for Disease Control (ECDC)

Other EU Platforms
EU Health Policy Forum; HIV/AIDS Civil Society Forum (CSF); Pharmaceutical Forum
United Nations programs and organisations
UNAIDS, the Joint United Nations Programme on HIV/AIDS; World Health Organisation (WHO), the directing and coordinating authority for health within the United Nations
International Organisations
International Organisation for Migration (IOM); International Harm Reduction Association (IHRA); International AIDS Society (IAS); International Planned Parenthood Federation (IPPF)

HIV/AIDS Organisations and Networks
AIDS Action Europe; AIDS Treatment Activists Coalition (ATAC); International Treatment Preparedness Coalition (ITPC); Global Network of People Living with HIV/AIDS (GNP+); International Community of Women Living with HIV/AIDS (ICW); Eastern European & Central Asian Union of PLWH Organisations (ECUO); Global Campaign for Microbicides (GCM); International AIDS Vaccine Initiative (IAVI); AIDS Vaccine Advocacy Coalition (AVAC); HIV in Europe; NAM; Terrence Higgins Trust (THT)

Public Health Networks
European Public Health Alliance (EPHA); Concord; EU Civil Society Contact Group; International Harm Reduction Development Program (IHRD); Eurasian Harm Reduction Network (EHRN); Health Action international (HAI); Médecins Sans Frontières (MSF), European Forum for Good Clinical Practice (EFGCP)

EATG involvement via projects
AIDS and Mobility Europe; AIDS Action Integration; European HIV Resistance Network; HIV/STI Prevention & Health Promotion among Migrant Sex Workers (TAMPEP); Health GAP (Global Access Project);

Other European organisations
European Patients’ Forum (EPF); International Alliance of Patient Organisations (IAPO); European Forum for Good Clinical Practice (EFGCP); European Federation of Pharmaceutical Industries and Associations (EFPIA); European Coalition of Positive People (ECPP); European AIDS Clinical Society (EACS); European Platform for Patients Organisations, Science and Industry (EPPOSI)

Other organisations and networks
Platform for International Cooperation on Undocumented Migrants (PICUM); Open Society Institute (OSI); Human Rights Watch (HRW); Correlation European Network Social Inclusion and Health; The Global Fund to fight AIDS, Tuberculosis and Malaria (GFTAM); Global Health Council; Association Internationale de la Mutualité (AIM); European Consumer’s Organisation (BEUC); Comité Permanent des Médecins Européens (CPME); the European Network on Drugs and Infections Prevention in Prison (ENDIPP)

None declared

Jan 2017 - Dec 2017

24,269€

135,399 € (Source: H2020 FP7)

None declared

Commission expert group - Civil Society Forum on Drugs#E02681 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=2681 #Member #C#Sub-group on Relations with International Institutions#EU HIV/AIDS, Viral Hepatitis and Tuberculosis Civil Society Forum#E00934 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=934 #Member #C#EU HIV/AIDS, Viral Hepatitis and Tuberculosis Think Tank#E00933 #http://ec.europa.eu/transparency/regexpert/index.cfm?do=groupDetail.groupDetail&groupID=933 #Observer #C

None

HIV in Europe is a pan-European initiative initiated in Brussels in 2007. The initiative provides a European platform for exchange and activities to improve early diagnosis and earlier care of HIV across Europe. The initiative is directed by a Steering Committee composed of physicians, researchers, civil society actors, policy-makers of national and European public health institutions. It is increasingly collaborating with the Hepatitis community.
The EMERGE project (Evaluating mHealth technology in HIV to improve Empowerment and healthcare utilisation: Research and innovation to Generate Evidence for personalised care) is a mHealth platform to enable self-management of HIV in patients with stable disease. The platform will provide users with web based and mobile device applications which interface securely with relevant medical data and facilitate remote access to key healthcare providers. EATG will be acting as community partner, supporting standards for HIV care and guidelines for routine monitoring both in the involved countries and more broadly across the EU and potentially wider.
ESTICOM – EUROPEAN SURVEYS AND TRAININGS TO IMPROVE MSM COMMUNITY HEALTH aims to strengthen the community response and raise awareness about the persisting legal, structural, political and social barriers hindering a more effective response to the syndemics of HIV, hepatitis viruses B and C, and other STI among MSM. The main activities include surveys among MSM (EMIS2017) and Community Based Health Workers (ECHOES) as well as a training programme for Community Health Workers intended to be adaptable for all EU countries.
HIVACAR – EVALUATING A COMBINATION OF IMMUNE-BASED THERAPIES TO ACHIEVE A FUNCTIONAL CURE OF HIV INFECTION. The project aims to change the current paradigm of HIV treatment by obtaining a functional cure for HIV thanks to effectively targeting residual virus replication and viral reservoirs.
EHVA – EUROPEAN HIV VACCINE ALLIANCE, AN EU PLATFORM FOR THE DISCOVERY AND EVALUATION OF NOVEL PROPHYLACTIC AND THERAPEUTIC VACCINE CANDIDATES. Project aims: To develop a Multidisciplinary Vaccine Platform (MVP) in the fields of prophylactic and therapeutic HIV vaccines. The MVP includes four components: 1) Discovery, 2) Immune Profiling, 3) Data Management, Integration and Down-Selection, and 4) Clinical Trials.
HAND – HEPATITIS ACCESS NEEDS. Project aims: To address the specific access needs within co-infected key populations to hepatitis prevention, testing, treatment and care services in Europe (with a special focus on EECA region), and to improve the capacity of key community leaders to further educate and support local community members and improve community involvement in treatment related advocacy and activism. The project has two main components: research and training. The research focuses on the access to hepatitis testing, treatment and care among people in detention and migrants. The training part provides targeted information on treatment and prevention of Hepatitis B and C through webinars in English/Russian and contributes to community mobilization via advocacy-focused workshops, organised in collaboration with local partners.

 Previous projects
EUPATI was an IMI-funded consortium project, led by the European Patients' Forum, to educate patients and the lay public about how medicines’ R&D works. A consortium of 29 organisations is developing training courses, educational toolkits and a web-based library to provide objective and credible information about medicines R&D and how patients can get involved. EUPATI will cover seven languages in 12 countries.

The main activity of work package 7 (WP7) was the preparation of a catalogue and a report on successful public private partnerships (PPPs) between patients’ organisations, industry and academia. The catalogue provides references and examples of successful collaborations that can be used as guidance for future partnerships, addressing the need for more active involvement of patient experts in medicines R&D.

The previous consortium has developed a follow up of the project for further implementation of the activities after the end of the project.

NEAT - European AIDS Treatment Network was a network of Excellence funded by the European Commission under the FP6 Programme. Its mission was to strengthen European HIV clinical research capacity. Nikos Dedes is the EATG project leader. The final version of the ECAB Review (which was funded by NEAT) has been published in June (see 3.5 The ECAB Review).

ECRAN – European Communication on Research Awareness Needs project was designed to develop a portfolio of open educational resources, including a film, for the general population about the challenges raised by independent clinical research. EATG was a non-leading partner in 4 work packages of the project: Creation of a multi-language website, Production of an animated film on clinical trials, planning and development of communication tools and materials.

EuroCoord was a Network of Excellence established by several of the biggest HIV cohorts and collaborations within Europe.
Project aims: The overarching aim of EuroCoord was to use the scientific strengths of each collaboration to ensure that the best, most competitive research is performed. EuroCoord’s multidisciplinary approach allowed key areas of HIV research to be addressed, aimed at improving the management and life of HIV-infected.

2 meetings found. Download meetings

The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.

• Date	22 Jul 2019	Location	Brussels
  Subject	Access to medicines
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Alina Timofte (Cabinet member) Arunas Vinciunas (Cabinet member) Vytenis Andriukaitis (Commissioner)
  Other Lobbyists	The European Association of Hospital Pharmacists Association Belge des Consommateurs Test-Achats / Belgische Verbruikersunie Test-Aankoop

• Date	28 Nov 2016	Location	Brussels
  Subject	EU and NGOs action on HIV, TB and Hepatitis
  Cabinet	Cabinet of Commissioner Vytenis Andriukaitis
  Portfolio	Health & Food Safety
  Attending	Paula Duarte Gaspar (Cabinet member) Vytenis Andriukaitis (Commissioner)
  Other Lobbyists	European Liver Patients' Association Deutsche Aidshilfe GLOBAL HEALTH ADVOCATES